Test for the detection of 10 pathogens associated to sexual transmitted diseases

The STD Panel Strip test is a test based on the reverse blot technique that allows the detection of 10 pathogens associated to sexually transmitted diseases.

At present, sexually transmitted diseases (STDs) make up the most common group of infectious diseases that must be reported in the majority of the world’s countries. Their incidence is elevated, exceeding one million infections per day. In fact, this current trend of permanent increase, especially among young people under 25 years, makes the early and accurate diagnosis of the disease of great interest.

Although there are several microorganisms that can be transmitted by sexual contact, only few of them cause the majority of the infections. Among the most common are: Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma (genitalium and hominis).

The majority of STDs have treatments and are curable. However, an untreated STD can lead to serious long-term health problems.

The STD Panel Strip test allows the detection of 10 pathogens associated to sexual transmitted diseases: Chlamydia trachomatis (discriminating variants L1, L2 and L3, that cause lymphogranuloma venereum), Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Herpes simplex 1, Herpes simplex 2, and Treponema pallidum

alta sensibilidad especifidad

High sensitivity and specificity

deteccion de coinfecciones

Detection of co-infections

search 1

10 pathogens in one test

diferenciacion identificacion virus variantes

Differentiates between HSV1 and HSV2

diferenciacion identificacion virus variantes

Differentiation of LGV causative variants

Our products for the detection of 10 pathogens associated to sexual transmitted diseases

Promotional Sheet
CE Decl.
Catalogue No.
STD Panel Strip
Hybridization on Strip
DNA from smears of various origins (urethral, endocervical, rectal, vaginal) and urine

Detection of 10 of the most common pathogens that cause sexually transmitted diseases in a single strip. Each pathogen is detected in a different line, which makes this test the ideal tool for detecting co-infections. Co-infections in STDs are very frequent, especially considering that some pathogens, such as ureaplasmas, are part of the normal flora of the male and female genitalia. In fact, 30-40% of cases have co-infection with up to two different pathogens, and up to 20% may have up to four pathogens.

Differentiation between Herpes simplex 1 (HSV1) and Herpes simplex 2 (HSV2), in separate bands. This is very useful for epidemiological studies, and for more specific monitoring of the infection, as it allows easy differentiation.

Differentiation between L1, L2 and L3 variants of Chlamydia. Treatment for lymphogranuloma infection is longer than for other Chlamydia variants, so it is important to distinguish between them to provide a more accurate diagnosis. The test also detects the Swedish variant.

Several types of validated samples. Depending on the symptoms of the patient, the sample should be taken from one site or another in order to ensure that as much of the pathogen as possible has been taken. Therefore, the STD Panel Strip has been validated for its use with several samples: urine and urethral, cervical, endocervical, rectal and vaginal smears.


Prueba molecular de detección de Enfermedades de Transmisión Sexual
Contact us for more

    Frequently Asked Questions

    It depends on the disease. For Chlamydia trachomatis infections, the period is usually between 7 and 21 days. For herpes simplex virus, 2 to 12 days. For Neisseria gorrorhoeae, 1 to 14 days. For Hepatitis A, 15 to 50 days; for Hepatitis B, 8 to 22 days; and for Hepatitis C, 2 to 26 weeks. For HIV, 2 to 4 weeks. For human papillomavirus (HPV), 1 month to 10 years. For Treponema pallidum, 3 weeks to 20 years. For Trichomonas vaginalis, 5 to 28 days.
    How long it takes for an STD to show up in testing is entirely dependent on the STD itself, how long its own incubation period is, and the body’s immune response. Some STDs, like chlamydia, can be tested only a day after potential exposure. Meanwhile, HIV and syphilis can take a month or more before they can be tested.
    The test has been designed and validated for use with DNA obtained from smears of various origins (urethral, endocervical, rectal, vaginal), and from urine. For the smears, use sterile and dry cotton swabs or brushes to take the sample. Ensure enough sample is obtained, but without causing bleeding. Place the swab in a tube in an adequate transport medium (for example, Amies-Stuart medium or Cobas PCR Female Swab Sample Packet by Roche Molecular Systems). For urine samples, you should ask the patient to collect the first 10-20 ml of urine in a sterile tube, having refrained from urinating for at least two hours before sampling. The quality and concentration of the DNA extracted is of vital importance for the proper performance of the kit. The presence of inhibitors in the sample or low DNA concentration could reduce the sensitivity of the test. DNA samples should be stored at 2-8°C if they are going to be analysed within a short time, or at -20°C for longer storage. Freezing the sample may reduce the sensitivity of the assay if the amount of DNA present is very low. Therefore, it is important to ensure that an appropriate extraction method is used to obtain as much DNA as possible.
    Preservative-free urine and urine in the Cobas PCR urine sample kit have been validated. Extraction is likely to eliminate possible interfering substances, but must be validated by the user.